Drug for treating coronaviral and retroviral infections and hepatitis c
AssigneeVladislav Nikolaevich LASKAVYI
InventorsVladislav Nikolaevich LASKAVYI, Mikhail Arkadevich SHURDOV
Life of this patent
Estimating the term…
Loading patent…
AssigneeVladislav Nikolaevich LASKAVYI
InventorsVladislav Nikolaevich LASKAVYI, Mikhail Arkadevich SHURDOV
Estimating the term…
The invention relates to medicine and veterinary medicine, and more specifically, to pharmacology, and can be used to treat viral infections caused by RNA viruses that have a lipid envelope, in particular coronaviral infections, AIDS and hepatitis C. The invention extends the range of drugs for the claimed purpose. The technical result is the creation of a drug having an intracellular, antiseptic effect that activates the production of endogenous formaldehyde in the body of a human and animals without having side effects and toxicity. The technical result is achieved by the use of an immunomodulating drug comprising 0.073-0.075% of formaldehyde in an isotonic solution of sodium chloride as a drug for intramuscular injections with a single 5 ml injection dosage for treating coronaviral and retroviral infections and hepatitis C.
The use of the immunomodulating agent containing formic aldehyde in an amount of 0.073-0.075% in isotonic sodium chloride solution as an agent for intramuscular injections with a single dose of 5 mL per injection for the treatment of coronavirus, retroviral infections and hepatitis C.
Dependencies are inferred from the claim text.